Analysts' Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)

TipRanksMar 11 03:31 ET · Ratings

Lexicon Pharmaceuticals Faces Supply Chain Risks Amidst Changing Trade Policies

TipRanksMar 9 01:00 ET

Benign Growth For Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Underpins Stock's 48% Plummet

Simply Wall StMar 8 09:16 ET

Lexicon Pharmaceuticals' Mixed Earnings Call: Achievements and Challenges

TipRanksMar 7 19:19 ET

Lexicon Pharmaceuticals | 10-K: FY2024 Annual Report

SECMar 7 16:03 ET · Announcements

Lexicon Pharmaceuticals GAAP EPS of -$0.09 Beats by $0.02, Revenue of $26.6M Beats by $24.6M

Seeking AlphaMar 7 12:07 ET